BRIEF-FDA approves Biogen Idec's Tecfidera for Multiple Sclerosis

March 27 (Reuters) - U.S. Food and Drug Administration:

* FDA says approved Biogen idec's tecfidera (dimethyl fumarate)

capsules to treat adults with relapsing forms of Multiple Sclerosis

* Source text for Eikon:

* Further company coverage ((Bangalore Newsroom; +1 646 223 8780))

View the original article here